MeVis Medical Solutions AG (M3V) - Total Liabilities
Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has total liabilities worth €8.06 Million EUR (≈ $9.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore MeVis Medical Solutions AG annual equity growth to track the company's year-over-year net asset growth rate.
MeVis Medical Solutions AG - Total Liabilities Trend (2006–2025)
This chart illustrates how MeVis Medical Solutions AG's total liabilities have evolved over time, based on quarterly financial data. See MeVis Medical Solutions AG (M3V) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
MeVis Medical Solutions AG Competitors by Total Liabilities
The table below lists competitors of MeVis Medical Solutions AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DESWELL INDS INC. DL-01
F:DW2
|
Germany | €20.17 Million |
|
JSS Real Estate SOCIMI SA
MC:YJSS
|
Spain | €291.53 Million |
|
Bever Holding NV
AS:BEVER
|
Netherlands | €13.49 Million |
|
OS Therapies Incorporated
NYSE MKT:OSTX
|
USA | $4.25 Million |
|
Oceanpal Inc
NASDAQ:OP
|
USA | $4.10 Million |
|
Shuang-Bang Industrial
TWO:6506
|
Taiwan | NT$1.23 Billion |
|
Adaptimmune Therapeutics plc
F:473A
|
Germany | €201.59 Million |
|
Minesto AB
ST:MINEST
|
Sweden | Skr22.24 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down MeVis Medical Solutions AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see M3V company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MeVis Medical Solutions AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MeVis Medical Solutions AG (2006–2025)
The table below shows the annual total liabilities of MeVis Medical Solutions AG from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | €8.06 Million ≈ $9.42 Million |
-6.90% |
| 2024-09-30 | €8.66 Million ≈ $10.12 Million |
-15.35% |
| 2023-09-30 | €10.23 Million ≈ $11.96 Million |
-23.53% |
| 2022-09-30 | €13.38 Million ≈ $15.64 Million |
+37.78% |
| 2021-09-30 | €9.71 Million ≈ $11.35 Million |
-2.58% |
| 2020-09-30 | €9.96 Million ≈ $11.65 Million |
+63.53% |
| 2019-09-30 | €6.09 Million ≈ $7.12 Million |
-4.19% |
| 2018-09-30 | €6.36 Million ≈ $7.44 Million |
-61.61% |
| 2017-09-30 | €16.57 Million ≈ $19.37 Million |
+63.81% |
| 2016-09-30 | €10.11 Million ≈ $11.82 Million |
-14.43% |
| 2015-09-30 | €11.82 Million ≈ $13.82 Million |
+48.05% |
| 2014-09-30 | €7.98 Million ≈ $9.33 Million |
+0.71% |
| 2013-09-30 | €7.93 Million ≈ $9.27 Million |
-2.68% |
| 2012-09-30 | €8.15 Million ≈ $9.52 Million |
-31.08% |
| 2011-09-30 | €11.82 Million ≈ $13.82 Million |
-15.55% |
| 2010-09-30 | €14.00 Million ≈ $16.36 Million |
-23.72% |
| 2009-09-30 | €18.35 Million ≈ $21.45 Million |
-31.98% |
| 2008-09-30 | €26.97 Million ≈ $31.53 Million |
+461.24% |
| 2007-09-30 | €4.81 Million ≈ $5.62 Million |
-25.49% |
| 2006-09-30 | €6.45 Million ≈ $7.54 Million |
-- |
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more